Rapid Syndromic Testing for All Labs

The mission of iCubate® is to provide rapid, accurate and affordable syndromic testing to all laboratories to ensure care providers have the right tools to improve care and outcomes for their patients. The iCubate® team has developed the iC System™, a low-cost, fully automated, molecular diagnostic platform using armPCR technology, along with a suite of syndromic infectious diseases panels, including sepsis/positive blood cultures, upper / lower respiratory tract infections, GI, mycobacteria, and more.

Why iCubate for your lab?
•	Rapid syndromic testing for infectious diseases for better care, sooner
•	Affordable system increasing accessibility for large and small labs
•	Multiplex assay with high target specificity and sensitivity for actionable results
•	3 minutes of hands-on time with routine lab processes

Twitter: @iCubate

FDA Cleared Products
iC-System™ (iCubate’s platform)
iC-GPC Assay™ for Gram positive cocci

Anticipated clearance 2019
iC-GN Assay™ for Gram negative rods

Robust Assay Pipeline 
GI, Respiratory, Mycobacterium

iCubate® MDx

Org chart

Teams

Offices

iCubate® MDx

Org chart

Teams

Offices

Related companies